Project cooperationUpdated on 21 January 2026
Clinical collaboration for thyroid cancer and thyroid disease biospecimen collection
Associate Professor of Surgery, University of Cagliari at University of Cagliari (UNICA)
Cagliari, Italy
About
Our clinical unit is available to collaborate within a Horizon project by providing access to surgical thyroid specimens and associated biological materials from patients undergoing surgery for thyroid cancer and other thyroid pathologies. We routinely perform around 400 thyroidectomies annually, ensuring a stable recruitment base and consistent availability of samples across a broad spectrum of thyroid conditions.
Within a project framework, we can:
-
Collect surgical thyroid tissue specimens generated during standard-of-care procedures (e.g., tumor and non-tumor tissue, when applicable).
-
Collect and provide additional biological samples as defined by the protocol (e.g., blood-derived samples or other biospecimens, depending on study needs and feasibility).
-
Process, store, and prepare samples for transfer, and ship biospecimens to project partners, in accordance with agreed SOPs and applicable ethical/legal requirements.
-
Support clinical annotation of samples (e.g., basic demographics, diagnosis, surgical details, pathology results, outcomes), subject to approvals and data governance.
This cooperation is intended for partners seeking clinically sourced biospecimens to enable translational research, biomarker discovery/validation, molecular profiling, or the development of diagnostic/prognostic tools in thyroid oncology and thyroid disease. Sample types, handling requirements, timelines, and data fields can be aligned to the consortium protocol.
Topic
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
NAM: organoids and OoC for drug discovery, and precision medicine applications
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Una Riekstina
full professor at Department of Pharmaceutical Sciences, University of Latvia
Riga, Latvia
Project cooperation
Clinical Training & Validation Partner for Horizon Health Consortia
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
Luca Takács
Founder and CEO at LNP Academy
Budapest, Hungary
Project cooperation
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Fernando Torres Andón
Miguel Servet Researcher at INIBIC
A Coruña, Spain